Guest guest Posted October 22, 2011 Report Share Posted October 22, 2011 Pharmasset Falls on Rival Abbott Hepatitis C Therapy Results BusinessWeek By Pat Wechsler Oct. 21 (Bloomberg) -- Pharmasset Inc., developer of anti- viral medicines, plunged the most ever after Abbott Laboratories said interim study results of its rival experimental hepatitis C therapy showed high cure rates. .... See all stories on this topic »European studies on risks of hepatocellular carcinoma EurekAlert (press release) Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to a cohort study published ... See all stories on this topic » Abbott says hepatitis C combo may be a blockbuster Reuters By Ransdell Pierson and Bill Berkrot NEW YORK, Oct 21 (Reuters) - Abbott Laboratories Inc said on Friday that it could have a shorter duration combination therapy for hepatitis C on the market in 2015 with annual sales potential of about $2 billion. ... See all stories on this topic »New drug boosts hepatitis treatment Rutland and Stamford Mercury Thousands of hepatitis C patients across the North West are set to benefit from a new treatment, according to research. Around 29503 people in the region have been diagnosed with the blood-borne infection that attacks the liver, according to figures. ... See all stories on this topic »HIV And Hepatitis Exposed To 6800 At Clinic ThirdAge The new test will be used on June 27, 2003, which in national HIV testing day..mk/ Kleinfeld UPI At least 6800 patients may have contracted HIV or hepatitis at a Canadian doctor's clinic. The doctor apologized Monday as health officials alerted ... See all stories on this topic » ThirdAgeIntegrate Hepatitis C testing with HIV: NGOs Daily News & Analysis With over 13 million cases of Hepatitis C Virus (HCV) in India, NGOs Friday urged the National AIDS Control Organisation (NACO) to include testing and treatment guidelines for the disease in its intervention targeted at HIV patients. ... See all stories on this topic »New Boehringer Ingelheim Hepatitis C Data to Be Presented at AASLD Times Colonist Boehringer Ingelheim announced today that new data from its hepatitis C virus (HCV) portfolio will be presented in scientific sessions at The Liver Meeting® 2011, the 62 nd Annual Meeting of the American Association for the Study of Liver Diseases ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 22, 2011 Report Share Posted October 22, 2011 Pharmasset Falls on Rival Abbott Hepatitis C Therapy Results BusinessWeek By Pat Wechsler Oct. 21 (Bloomberg) -- Pharmasset Inc., developer of anti- viral medicines, plunged the most ever after Abbott Laboratories said interim study results of its rival experimental hepatitis C therapy showed high cure rates. .... See all stories on this topic »European studies on risks of hepatocellular carcinoma EurekAlert (press release) Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to a cohort study published ... See all stories on this topic » Abbott says hepatitis C combo may be a blockbuster Reuters By Ransdell Pierson and Bill Berkrot NEW YORK, Oct 21 (Reuters) - Abbott Laboratories Inc said on Friday that it could have a shorter duration combination therapy for hepatitis C on the market in 2015 with annual sales potential of about $2 billion. ... See all stories on this topic »New drug boosts hepatitis treatment Rutland and Stamford Mercury Thousands of hepatitis C patients across the North West are set to benefit from a new treatment, according to research. Around 29503 people in the region have been diagnosed with the blood-borne infection that attacks the liver, according to figures. ... See all stories on this topic »HIV And Hepatitis Exposed To 6800 At Clinic ThirdAge The new test will be used on June 27, 2003, which in national HIV testing day..mk/ Kleinfeld UPI At least 6800 patients may have contracted HIV or hepatitis at a Canadian doctor's clinic. The doctor apologized Monday as health officials alerted ... See all stories on this topic » ThirdAgeIntegrate Hepatitis C testing with HIV: NGOs Daily News & Analysis With over 13 million cases of Hepatitis C Virus (HCV) in India, NGOs Friday urged the National AIDS Control Organisation (NACO) to include testing and treatment guidelines for the disease in its intervention targeted at HIV patients. ... See all stories on this topic »New Boehringer Ingelheim Hepatitis C Data to Be Presented at AASLD Times Colonist Boehringer Ingelheim announced today that new data from its hepatitis C virus (HCV) portfolio will be presented in scientific sessions at The Liver Meeting® 2011, the 62 nd Annual Meeting of the American Association for the Study of Liver Diseases ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.